Antibacterial	B:C0279516
Activity	O
of	O
Polyaniline	O
Coated	O
Silver	O
Nanoparticles	O
Synthesized	O
from	O
Piper	O
Betle	I:C3643364
Leaves	I:C3643364
Extract	I:C3643364
.	O

Antibacterial	O
Activity	O
of	O
Polyaniline	B:C0962453
Coated	O
Silver	O
Nanoparticles	O
Synthesized	O
from	O
Piper	O
Betle	I:C3643364
Leaves	I:C3643364
Extract	I:C3643364
.	O

Antibacterial	O
Activity	O
of	O
Polyaniline	O
Coated	O
Silver	B:C0037125
Nanoparticles	O
Synthesized	O
from	O
Piper	O
Betle	I:C3643364
Leaves	I:C3643364
Extract	I:C3643364
.	O

Antibacterial	O
Activity	O
of	O
Polyaniline	O
Coated	O
Silver	O
Nanoparticles	O
Synthesized	O
from	O
Piper	B:C3643364
Betle	I:C3643364
Leaves	I:C3643364
Extract	I:C3643364
.	O

Plants	B:C0032098
or	O
natural	O
resources	O
have	O
been	O
found	O
to	O
be	O
a	O
good	O
alternative	O
method	O
for	O
nanoparticles	O
synthesis	O
.	O

In	O
this	O
study	B:C2603343
,	O
polyaniline	O
coated	O
silver	O
nanoparticles	O
(	O
AgNPs	O
)	O
synthesized	O
from	O
Piper	O
betle	I:C3643364
leaves	I:C3643364
extract	I:C3643364
were	O
investigated	O
for	O
their	O
antibacterial	O
activity	O
.	O

In	O
this	O
study	O
,	O
polyaniline	B:C0962453
coated	O
silver	O
nanoparticles	O
(	O
AgNPs	O
)	O
synthesized	O
from	O
Piper	O
betle	I:C3643364
leaves	I:C3643364
extract	I:C3643364
were	O
investigated	O
for	O
their	O
antibacterial	O
activity	O
.	O

In	O
this	O
study	O
,	O
polyaniline	O
coated	O
silver	B:C0037125
nanoparticles	O
(	O
AgNPs	O
)	O
synthesized	O
from	O
Piper	O
betle	I:C3643364
leaves	I:C3643364
extract	I:C3643364
were	O
investigated	O
for	O
their	O
antibacterial	O
activity	O
.	O

In	O
this	O
study	O
,	O
polyaniline	O
coated	O
silver	O
nanoparticles	O
(	O
AgNPs	O
)	O
synthesized	O
from	O
Piper	B:C3643364
betle	I:C3643364
leaves	I:C3643364
extract	I:C3643364
were	O
investigated	O
for	O
their	O
antibacterial	O
activity	O
.	O

In	O
this	O
study	O
,	O
polyaniline	O
coated	O
silver	O
nanoparticles	O
(	O
AgNPs	O
)	O
synthesized	O
from	O
Piper	O
betle	I:C3643364
leaves	I:C3643364
extract	I:C3643364
were	O
investigated	O
for	O
their	O
antibacterial	B:C0279516
activity	O
.	O

Silver	B:C0037125
nanoparticles	O
were	O
prepared	O
from	O
the	O
reduction	O
of	O
silver	O
nitrate	I:C0037129
and	O
NaBH4	O
was	O
used	O
as	O
reducing	O
agent	I:C0376446
.	O

Silver	O
nanoparticles	O
were	O
prepared	O
from	O
the	O
reduction	O
of	O
silver	B:C0037129
nitrate	I:C0037129
and	O
NaBH4	O
was	O
used	O
as	O
reducing	O
agent	I:C0376446
.	O

Silver	O
nanoparticles	O
were	O
prepared	O
from	O
the	O
reduction	O
of	O
silver	O
nitrate	I:C0037129
and	O
NaBH4	B:C0074728
was	O
used	O
as	O
reducing	O
agent	I:C0376446
.	O

Silver	O
nanoparticles	O
were	O
prepared	O
from	O
the	O
reduction	O
of	O
silver	O
nitrate	I:C0037129
and	O
NaBH4	O
was	O
used	O
as	O
reducing	B:C0376446
agent	I:C0376446
.	O

Silver	B:C0037125
nanoparticles	O
and	O
extracts	O
were	O
mixed	O
thoroughly	O
and	O
then	O
coated	O
by	O
polyaniline	O
.	O

Silver	O
nanoparticles	O
and	O
extracts	B:C0032081
were	O
mixed	O
thoroughly	O
and	O
then	O
coated	O
by	O
polyaniline	O
.	O

Silver	O
nanoparticles	O
and	O
extracts	O
were	O
mixed	O
thoroughly	O
and	O
then	O
coated	O
by	O
polyaniline	B:C0962453
.	O

Prepared	O
nanoparticles	O
were	O
characterized	O
by	O
Visual	O
inspection	O
,	O
Ultraviolet	B:C0037812
-	I:C0037812
visible	I:C0037812
spectroscopy	I:C0037812
(	O
Ultraviolet	O
-	I:C0037812
visible	I:C0037812
spectroscopy	I:C0037812
)	O
,	O
Fourier	O
transform	I:C0206055
infrared	I:C0206055
Spectroscopy	I:C0206055
(	O
Fourier	O
transform	I:C0206055
infrared	I:C0206055
Spectroscopy	I:C0206055
)	O
,	O
Transmission	O
Electron	I:C0678118
Microscopy	I:C0678118
(	I:C0678118
TEM	I:C0678118
)	I:C0678118
techniques	I:C0678118
.	O

Prepared	O
nanoparticles	O
were	O
characterized	O
by	O
Visual	O
inspection	O
,	O
Ultraviolet	O
-	I:C0037812
visible	I:C0037812
spectroscopy	I:C0037812
(	O
Ultraviolet	B:C0037812
-	I:C0037812
visible	I:C0037812
spectroscopy	I:C0037812
)	O
,	O
Fourier	O
transform	I:C0206055
infrared	I:C0206055
Spectroscopy	I:C0206055
(	O
Fourier	O
transform	I:C0206055
infrared	I:C0206055
Spectroscopy	I:C0206055
)	O
,	O
Transmission	O
Electron	I:C0678118
Microscopy	I:C0678118
(	I:C0678118
TEM	I:C0678118
)	I:C0678118
techniques	I:C0678118
.	O

Prepared	O
nanoparticles	O
were	O
characterized	O
by	O
Visual	O
inspection	O
,	O
Ultraviolet	O
-	I:C0037812
visible	I:C0037812
spectroscopy	I:C0037812
(	O
Ultraviolet	O
-	I:C0037812
visible	I:C0037812
spectroscopy	I:C0037812
)	O
,	O
Fourier	B:C0206055
transform	I:C0206055
infrared	I:C0206055
Spectroscopy	I:C0206055
(	O
Fourier	O
transform	I:C0206055
infrared	I:C0206055
Spectroscopy	I:C0206055
)	O
,	O
Transmission	O
Electron	I:C0678118
Microscopy	I:C0678118
(	I:C0678118
TEM	I:C0678118
)	I:C0678118
techniques	I:C0678118
.	O

Prepared	O
nanoparticles	O
were	O
characterized	O
by	O
Visual	O
inspection	O
,	O
Ultraviolet	O
-	I:C0037812
visible	I:C0037812
spectroscopy	I:C0037812
(	O
Ultraviolet	O
-	I:C0037812
visible	I:C0037812
spectroscopy	I:C0037812
)	O
,	O
Fourier	O
transform	I:C0206055
infrared	I:C0206055
Spectroscopy	I:C0206055
(	O
Fourier	B:C0206055
transform	I:C0206055
infrared	I:C0206055
Spectroscopy	I:C0206055
)	O
,	O
Transmission	O
Electron	I:C0678118
Microscopy	I:C0678118
(	I:C0678118
TEM	I:C0678118
)	I:C0678118
techniques	I:C0678118
.	O

Prepared	O
nanoparticles	O
were	O
characterized	O
by	O
Visual	O
inspection	O
,	O
Ultraviolet	O
-	I:C0037812
visible	I:C0037812
spectroscopy	I:C0037812
(	O
Ultraviolet	O
-	I:C0037812
visible	I:C0037812
spectroscopy	I:C0037812
)	O
,	O
Fourier	O
transform	I:C0206055
infrared	I:C0206055
Spectroscopy	I:C0206055
(	O
Fourier	O
transform	I:C0206055
infrared	I:C0206055
Spectroscopy	I:C0206055
)	O
,	O
Transmission	B:C0678118
Electron	I:C0678118
Microscopy	I:C0678118
(	I:C0678118
TEM	I:C0678118
)	I:C0678118
techniques	I:C0678118
.	O

Antibacterial	B:C0279516
activities	O
of	O
the	O
synthesized	O
silver	O
nanoparticles	O
were	O
tested	O
against	O
Staphylococcus	O
aureus	I:C0038172
ATCC	I:C0038172
25923	I:C0038172
,	O
Salmonella	O
typhi	I:C0036125
ATCC	I:C0036125
14028	I:C0036125
,	O
Escherichia	O
coli	I:C0014834
ATCC	I:C0014834
25922	I:C0014834
and	O
Pseudomonas	O
aeruginosa	I:C0033809
ATCC	I:C0033809
27853	I:C0033809
.	O

Antibacterial	O
activities	O
of	O
the	O
synthesized	O
silver	B:C0037125
nanoparticles	O
were	O
tested	O
against	O
Staphylococcus	O
aureus	I:C0038172
ATCC	I:C0038172
25923	I:C0038172
,	O
Salmonella	O
typhi	I:C0036125
ATCC	I:C0036125
14028	I:C0036125
,	O
Escherichia	O
coli	I:C0014834
ATCC	I:C0014834
25922	I:C0014834
and	O
Pseudomonas	O
aeruginosa	I:C0033809
ATCC	I:C0033809
27853	I:C0033809
.	O

Antibacterial	O
activities	O
of	O
the	O
synthesized	O
silver	O
nanoparticles	O
were	O
tested	O
against	O
Staphylococcus	B:C0038172
aureus	I:C0038172
ATCC	I:C0038172
25923	I:C0038172
,	O
Salmonella	O
typhi	I:C0036125
ATCC	I:C0036125
14028	I:C0036125
,	O
Escherichia	O
coli	I:C0014834
ATCC	I:C0014834
25922	I:C0014834
and	O
Pseudomonas	O
aeruginosa	I:C0033809
ATCC	I:C0033809
27853	I:C0033809
.	O

Antibacterial	O
activities	O
of	O
the	O
synthesized	O
silver	O
nanoparticles	O
were	O
tested	O
against	O
Staphylococcus	O
aureus	I:C0038172
ATCC	I:C0038172
25923	I:C0038172
,	O
Salmonella	B:C0036125
typhi	I:C0036125
ATCC	I:C0036125
14028	I:C0036125
,	O
Escherichia	O
coli	I:C0014834
ATCC	I:C0014834
25922	I:C0014834
and	O
Pseudomonas	O
aeruginosa	I:C0033809
ATCC	I:C0033809
27853	I:C0033809
.	O

Antibacterial	O
activities	O
of	O
the	O
synthesized	O
silver	O
nanoparticles	O
were	O
tested	O
against	O
Staphylococcus	O
aureus	I:C0038172
ATCC	I:C0038172
25923	I:C0038172
,	O
Salmonella	O
typhi	I:C0036125
ATCC	I:C0036125
14028	I:C0036125
,	O
Escherichia	B:C0014834
coli	I:C0014834
ATCC	I:C0014834
25922	I:C0014834
and	O
Pseudomonas	O
aeruginosa	I:C0033809
ATCC	I:C0033809
27853	I:C0033809
.	O

Antibacterial	O
activities	O
of	O
the	O
synthesized	O
silver	O
nanoparticles	O
were	O
tested	O
against	O
Staphylococcus	O
aureus	I:C0038172
ATCC	I:C0038172
25923	I:C0038172
,	O
Salmonella	O
typhi	I:C0036125
ATCC	I:C0036125
14028	I:C0036125
,	O
Escherichia	O
coli	I:C0014834
ATCC	I:C0014834
25922	I:C0014834
and	O
Pseudomonas	B:C0033809
aeruginosa	I:C0033809
ATCC	I:C0033809
27853	I:C0033809
.	O

UV	B:C0037812
-	I:C0037812
Vis	I:C0037812
spectrum	I:C0037812
of	O
reaction	O
mixture	O
showed	O
strong	O
absorption	O
peak	O
with	O
centering	O
at	O
400	O
nm	O
.	O

The	O
Fourier	B:C0206055
transform	I:C0206055
infrared	I:C0206055
Spectroscopy	I:C0206055
results	O
imply	O
that	O
Ag	O
-	O
NPs	O
were	O
successfully	O
synthesized	O
and	O
capped	O
with	O
bio-compounds	O
present	O
in	O
P.	O
betle	I:C3643364
.	O

The	O
Fourier	O
transform	I:C0206055
infrared	I:C0206055
Spectroscopy	I:C0206055
results	B:C0587081
imply	O
that	O
Ag	O
-	O
NPs	O
were	O
successfully	O
synthesized	O
and	O
capped	O
with	O
bio-compounds	O
present	O
in	O
P.	O
betle	I:C3643364
.	O

The	O
Fourier	O
transform	I:C0206055
infrared	I:C0206055
Spectroscopy	I:C0206055
results	O
imply	O
that	O
Ag	O
-	O
NPs	O
were	O
successfully	O
synthesized	O
and	O
capped	O
with	O
bio-compounds	O
present	O
in	O
P.	B:C3643364
betle	I:C3643364
.	O

Transmission	B:C0678118
Electron	I:C0678118
Microscopy	I:C0678118
image	O
showed	O
that	O
Ag	O
-	O
NPs	O
formed	O
were	O
well	O
dispersed	O
with	O
a	O
spherical	O
structures	I:C0332501
and	O
particle	O
size	O
ranging	O
from	O
10	O
to	O
30	O
nm	O
.	O

Transmission	O
Electron	I:C0678118
Microscopy	I:C0678118
image	O
showed	O
that	O
Ag	O
-	O
NPs	O
formed	O
were	O
well	O
dispersed	B:C0332624
with	O
a	O
spherical	O
structures	I:C0332501
and	O
particle	O
size	O
ranging	O
from	O
10	O
to	O
30	O
nm	O
.	O

Transmission	O
Electron	I:C0678118
Microscopy	I:C0678118
image	O
showed	O
that	O
Ag	O
-	O
NPs	O
formed	O
were	O
well	O
dispersed	O
with	O
a	O
spherical	B:C0332501
structures	I:C0332501
and	O
particle	O
size	O
ranging	O
from	O
10	O
to	O
30	O
nm	O
.	O

The	O
result	O
revealed	O
that	O
Ag	O
-	O
Extract	O
NPs	O
showed	O
32.78±0.64	O
mm	O
zone	O
of	O
inhibition	O
against	O
S.	B:C0038172
aureus	I:C0038172
,	O
whereas	O
norfloxacin	O
(	O
positive	O
control	O
)	O
showed	O
maximum	O
32.15±0.40	O
mm	O
zone	O
of	O
inhibition	O
for	O
S.	O
aureus	I:C0038172
.	O

The	O
result	O
revealed	O
that	O
Ag	O
-	O
Extract	O
NPs	O
showed	O
32.78±0.64	O
mm	O
zone	O
of	O
inhibition	O
against	O
S.	O
aureus	I:C0038172
,	O
whereas	O
norfloxacin	B:C0028365
(	O
positive	O
control	O
)	O
showed	O
maximum	O
32.15±0.40	O
mm	O
zone	O
of	O
inhibition	O
for	O
S.	O
aureus	I:C0038172
.	O

The	O
result	O
revealed	O
that	O
Ag	O
-	O
Extract	O
NPs	O
showed	O
32.78±0.64	O
mm	O
zone	O
of	O
inhibition	O
against	O
S.	O
aureus	I:C0038172
,	O
whereas	O
norfloxacin	O
(	O
positive	O
control	O
)	O
showed	O
maximum	O
32.15±0.40	O
mm	O
zone	O
of	O
inhibition	O
for	O
S.	B:C0038172
aureus	I:C0038172
.	O

Again	O
,	O
maximum	B:C1710706
zone	I:C1710706
of	O
inhibition	O
29.55±0.45	O
mm	O
was	O
found	O
for	O
S.	O
typhi	I:C0036125
,	O
27.12±0.38	O
mm	O
for	O
E.	O
coli	I:C0014834
and	O
21.95±0.45	O
mm	O
for	O
P.	O
aeruginosa	I:C0033809
.	O

Again	O
,	O
maximum	O
zone	I:C1710706
of	O
inhibition	O
29.55±0.45	O
mm	O
was	O
found	O
for	O
S.	B:C0036125
typhi	I:C0036125
,	O
27.12±0.38	O
mm	O
for	O
E.	O
coli	I:C0014834
and	O
21.95±0.45	O
mm	O
for	O
P.	O
aeruginosa	I:C0033809
.	O

Again	O
,	O
maximum	O
zone	I:C1710706
of	O
inhibition	O
29.55±0.45	O
mm	O
was	O
found	O
for	O
S.	O
typhi	I:C0036125
,	O
27.12±0.38	O
mm	O
for	O
E.	B:C0014834
coli	I:C0014834
and	O
21.95±0.45	O
mm	O
for	O
P.	O
aeruginosa	I:C0033809
.	O

Again	O
,	O
maximum	O
zone	I:C1710706
of	O
inhibition	O
29.55±0.45	O
mm	O
was	O
found	O
for	O
S.	O
typhi	I:C0036125
,	O
27.12±0.38	O
mm	O
for	O
E.	O
coli	I:C0014834
and	O
21.95±0.45	O
mm	O
for	O
P.	B:C0033809
aeruginosa	I:C0033809
.	O

The	O
results	O
obtained	O
by	O
this	O
study	B:C2603343
can't	O
be	O
directly	O
extrapolated	O
to	O
human	O
;	O
so	O
further	O
studies	I:C0008972
should	O
be	O
undertaken	O
to	O
established	O
the	O
strong	O
antimicrobial	O
activity	O
of	O
Ag	O
-	O
Extract	O
NPs	O
for	O
drug	O
development	I:C0872152
program	I:C0872152
.	O

The	O
results	O
obtained	O
by	O
this	O
study	O
can't	O
be	O
directly	O
extrapolated	O
to	O
human	B:C0086418
;	O
so	O
further	O
studies	I:C0008972
should	O
be	O
undertaken	O
to	O
established	O
the	O
strong	O
antimicrobial	O
activity	O
of	O
Ag	O
-	O
Extract	O
NPs	O
for	O
drug	O
development	I:C0872152
program	I:C0872152
.	O

The	O
results	O
obtained	O
by	O
this	O
study	O
can't	O
be	O
directly	O
extrapolated	O
to	O
human	O
;	O
so	O
further	B:C0008972
studies	I:C0008972
should	O
be	O
undertaken	O
to	O
established	O
the	O
strong	O
antimicrobial	O
activity	O
of	O
Ag	O
-	O
Extract	O
NPs	O
for	O
drug	O
development	I:C0872152
program	I:C0872152
.	O

The	O
results	O
obtained	O
by	O
this	O
study	O
can't	O
be	O
directly	O
extrapolated	O
to	O
human	O
;	O
so	O
further	O
studies	I:C0008972
should	O
be	O
undertaken	O
to	O
established	O
the	O
strong	O
antimicrobial	B:C1136254
activity	O
of	O
Ag	O
-	O
Extract	O
NPs	O
for	O
drug	O
development	I:C0872152
program	I:C0872152
.	O

The	O
results	O
obtained	O
by	O
this	O
study	O
can't	O
be	O
directly	O
extrapolated	O
to	O
human	O
;	O
so	O
further	O
studies	I:C0008972
should	O
be	O
undertaken	O
to	O
established	O
the	O
strong	O
antimicrobial	O
activity	O
of	O
Ag	O
-	O
Extract	O
NPs	O
for	O
drug	B:C0872152
development	I:C0872152
program	I:C0872152
.	O

